Page last updated: 2024-09-03

chymosin and dapagliflozin

chymosin has been researched along with dapagliflozin in 1 studies

Compound Research Comparison

Studies
(chymosin)
Trials
(chymosin)
Recent Studies (post-2010)
(chymosin)
Studies
(dapagliflozin)
Trials
(dapagliflozin)
Recent Studies (post-2010) (dapagliflozin)
1,01862581,4783681,407

Protein Interaction Comparison

ProteinTaxonomychymosin (IC50)dapagliflozin (IC50)
Sodium/glucose cotransporter 1Homo sapiens (human)1.1661
Sodium/glucose cotransporter 2Homo sapiens (human)0.0022
Sodium/myo-inositol cotransporter 2Homo sapiens (human)0.38
Solute carrier family 5 member 4Homo sapiens (human)0.0014

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ahn, YB; Chung, S; Kim, ES; Kim, JW; Kim, MJ; Kim, SJ; Ko, SH; Lee, EM; Moon, SD; Shin, SJ; Yoo, YH1

Other Studies

1 other study(ies) available for chymosin and dapagliflozin

ArticleYear
Effect of Sodium-Glucose Co-Transporter 2 Inhibitor, Dapagliflozin, on Renal Renin-Angiotensin System in an Animal Model of Type 2 Diabetes.
    PloS one, 2016, Volume: 11, Issue:11

    Topics: Aldosterone; Animals; Benzhydryl Compounds; Chymosin; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Disease Models, Animal; Glucosides; Hyperglycemia; Kidney; Lipid Peroxidation; Male; Rats, Inbred OLETF; Renin-Angiotensin System; Sodium-Glucose Transporter 2; Sodium-Glucose Transporter 2 Inhibitors

2016